e45 |
Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011
Sagar C. Patel, Jonathan Frandsen, Sudershan Bhatia, David GaffneySagar C. Patel, Jonathan Frandsen, Sudershan Bhatia, David Gaffney
KMSID: 1093769 J Gynecol Oncol. 2016;27(5):e45. Published online 2016 May 3 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e45 |
|
e46 |
Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancerComparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer
E Sun Paik, Tae-Joong Kim, Yoo-Young Lee, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo BaeE Sun Paik, Tae-Joong Kim, Yoo-Young Lee, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
KMSID: 1093770 J Gynecol Oncol. 2016;27(5):e46. Published online 2016 May 9 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e46 |
|
e47 |
Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancersBevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
Jovana Y. Martin, Renata R. Urban, John B. Liao, Barbara A. GoffJovana Y. Martin, Renata R. Urban, John B. Liao, Barbara A. Goff
KMSID: 1093771 J Gynecol Oncol. 2016;27(5):e47. Published online 2016 May 10 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e47 |
|
e48 |
Clinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiencesClinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences
Suwanit Therasakvichya, Sompop Kuljarusnont, Janjira Petsuksiri, Pattama Chaopotong, Vuthinun Achariyapota, Pisutt Srichaikul, Atthapon JaishuenSuwanit Therasakvichya, Sompop Kuljarusnont, Janjira Petsuksiri, Pattama Chaopotong, Vuthinun Achariyapota, Pisutt Srichaikul, Atthapon Jaishuen
KMSID: 1093772 J Gynecol Oncol. 2016;27(5):e48. Published online 2016 May 16 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e48 |
|
e49 |
Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatientsAssociations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients
Hye-Sun Kim, Tae Jin Kim, In-Ho Lee, Sung Ran HongHye-Sun Kim, Tae Jin Kim, In-Ho Lee, Sung Ran Hong
KMSID: 1093773 J Gynecol Oncol. 2016;27(5):e49. Published online 2016 May 16 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e49 |
|
e50 |
The 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10–13, 2016, GuangzhouThe 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10–13, 2016, Guangzhou
Ashvin Soochit, Chuyao Zhang, Jihong LiuAshvin Soochit, Chuyao Zhang, Jihong Liu
KMSID: 1093775 J Gynecol Oncol. 2016;27(5):e50. Published online 2016 September 4 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e50 |
|
e51 |
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational researchImmunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Sung-Jong Lee, Andrew Yang, T.-C. Wu, Chien-Fu HungSung-Jong Lee, Andrew Yang, T.-C. Wu, Chien-Fu Hung
KMSID: 1094335 J Gynecol Oncol. 2016;27(5):e51. Published online 2016 May 31 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e51 |
|
e52 |
Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancerNeoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
Jeongshim Lee, Tae Hyung Kim, Gwi Eon Kim, Ki Chang Keum, Yong Bae KimJeongshim Lee, Tae Hyung Kim, Gwi Eon Kim, Ki Chang Keum, Yong Bae Kim
KMSID: 1093777 J Gynecol Oncol. 2016;27(5):e52. Published online 2016 June 8 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e52 |
|
e54 |
Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasiaIdentification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
Kouichiro Kawano, Naotake Tsuda, Shin Nishio, Koji Yonemoto, Kazuto Tasaki, Rurika Tasaki, Kimio UshijimaKouichiro Kawano, Naotake Tsuda, Shin Nishio, Koji Yonemoto, Kazuto Tasaki, Rurika Tasaki, Kimio Ushijima
KMSID: 1093779 J Gynecol Oncol. 2016;27(5):e54. Published online 2016 June 22 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e54 |
|
e50 |
The 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10-13, 2016, GuangzhouThe 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10-13, 2016, Guangzhou
Ashvin Soochit, Chuyao Zhang, Jihong LiuAshvin Soochit, Chuyao Zhang, Jihong Liu
KMSID: 1148283 J Gynecol Oncol. 2016;27(5):e50. Published online 2016 May 27 DOI: http://dx.doi.org/10.3802/jgo.2016.27.e50 |
|